Patent classifications
A61G10/026
THERAPEUTIC DEVICE
The subject matter of the invention is a therapeutic device in the form of a cylindrical chamber which comprises a hyperbaric chamber, LED matrices (5) and inductive coil rings (10, 11, 12, 13), constructed in one inseparable set in the form of a chamber of 200-280 cm in length and diameter of the round cylinder (70-130 cm).
Multimodal Device for Transdermal Treatments
The present invention includes an apparatus for transdermal treatments comprising: an openable enclosure for a subject in communication with three or more sources of treatment modalities selected from: a source of ozone; a source of steam, a source of CO.sub.2/Carbonic Acid; a source of Far Infrared; and a source of pulsed electromagnetic fields (PEMF), wherein each of the three or more sources is in communication with an interior of the openable enclosure to treat the subject transdermally.
Hyperbaric Chamber with Therapeutic Pressure Control
The embodied invention is a pressure control system on a hyperbaric chamber where the pressure regulation is automatic, continuous, and independent of the flow curve of the air supply compressor. The chamber is continuously controlled by an air venting control valve with electronic control to provide tight control. The control is able to be programmed to provide a therapeutic, varying pressure for treatment.
Resuscitation chamber
A resuscitation chamber apparatus for administering hyperbaric oxygen to a patient. More particularly, the present invention relates to a hyperbaric oxygen compatible critical care chamber apparatus preferably for use in emergency departments and/or prehospital ambulance management of patients. In a preferred embodiment of the present invention, the apparatus is a resuscitation monoplace hyperbaric chamber preferably used in critical care management of acutely ill or injured patients in prehospital emergency medical services (EMS) settings or in hospital emergency departments. The apparatus preferably allows a critical care shock or arrested patient to be pressurized preferably without compromise for application of best medical equipment, medications and human resuscitating intervention.
METHOD FOR MODIFYING THE THERAPEUTIC EFFECTS OF DRUGS
A method for modifying the effect of a drug by application of an activation protocol, comprising: administering a drug according to a treatment protocol; applying an activation protocol in a timed relationship to the administering, for differentially activation of at least one selected brain region; wherein the differentially activation allows the drug to selectively interact with the at least one selected brain region.
Controller for an extremity hyperbaric device
A controller is operable to selectively supply gas to, and evacuate gas from, regions of a hyperbaric wound treatment chamber. The controller operates to inflate a passage or rib of the device to provide that the device is made sufficiently rigid for inserting a limb therethrough, and inflate an inflatable cuff to create a seal against the limb. The controller also operates to evacuate ambient air trapped within the chamber, and optionally partially evacuate the passage or rib, after the seal is created by the inflatable cuff, and then introduce oxygen into the chamber, and optionally inflate the passage or rib. The cuff, when inflated and creating a seal against a limb, optionally is at least partially within the chamber, and the treatment gas is supplied to the chamber to maintain the seal of the cuff against the limb.
Methods and devices for wound therapy
A system for wound treatment includes adjunctive wound therapy devices and substrates comprising multiple first reservoirs and multiple second reservoirs. Selected ones of the multiple first reservoirs include a reducing agent, and first reservoir surfaces of selected ones of the multiple first reservoirs are proximate to a first substrate surface. Selected ones of the multiple second reservoirs include an oxidizing agent, and second reservoir surfaces of selected ones of the multiple second reservoirs are proximate to the first substrate surface.
System for Cooling a Pressurized Hyperbaric Chamber without Pressure Change
A system for cooling a pressurized hyperbaric chamber without pressure change includes an air compressing unit, an air cooling unit, and an air discharging hose. The pressurized hyperbaric chamber, the air compressing unit, the air cooling unit, and the air discharging hose are in fluid communication with each other. A flow of output warm air from the pressurized hyperbaric chamber is withdrawn and discharged into the air cooling unit by the air compressing unit. A heat exchanger of the air cooling unit then removes heat energy from the flow of output warm air to convert the flow of output warm air into a flow of input cold air, as the heat exchanger is in fluid communication with stored ice water within an insulated reservoir of the air cooling unit. The flow of input cold air is then discharged back into the pressurized hyperbaric chamber through the air discharging hose.
FOLDABLE INFLATABLE HYPERBARIC CHAMBER
The present disclosure provides a hyperbaric chamber that is capable of folding and unfolding, thereby reducing and increasing its inner volume, respectively. The inner volume is confined by a structural body and optionally also by top and bottom structural covers having a dome shape and being coupled to a structural body. The structural body, i.e., the structure that extends along a longitudinal axis of the chamber and grants the chamber a substantial portion of its geometric stability when the hyperbaric chamber is inflated with pressurized gas. The structural body is formed of two types of regions, a first, non-transparent region and a second, at least partially transparent region, both regions are reinforced to a degree for withstanding the desired internal pressure, namely a pressure difference between the internal volume of the chamber and the ambient pressure.
METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDAC1) SUBSTANCES
A method for treating cancer is described using combination therapies comprising the use of hyperbaric oxygen with histone deacetylase inhibitors, with and without glycolytic therapies. The patient is subjected to a hyperbaric environment of substantially pure oxygen. A predetermined dose of one or more HDACI substances is administered to the patient. In addition, glycolitic inhibitors may also be administered. Dosages, pressures, and durations are selected as described herein to have a therapeutic effect on the patient.